Thalidomide maintenance therapy for patients with multiple myeloma: meta-analysis

Leukemia Research
Yuki KagoyaMineo Kurokawa

Abstract

We performed a meta-analysis of randomized controlled trials comparing thalidomide maintenance with other regimens after induction chemotherapy for multiple myeloma. Overall, 6 trials including 2786 patients were identified. Patients treated with thalidomide maintenance had marginally better overall survival (hazard ratio HR 0.83, P=0.07). The improvement was especially prominent in a subgroup of studies using corticosteroids with thalidomide (HR 0.70, P=0.02). Thalidomide improved progression-free survival (HR 0.65, P<0.01), but had more frequent venous thrombosis (risk difference 0.024, P<0.05) and peripheral neuropathy (risk difference 0.072, P<0.01). These results suggest that thalidomide maintenance with corticosteroids is effective in prolonging survival for multiple myeloma.

References

Sep 1, 1986·Controlled Clinical Trials·R DerSimonian, N Laird
Nov 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S Vincent RajkumarThomas E Witzig
May 9, 2003·The New England Journal of Medicine·J Anthony ChildUNKNOWN Medical Research Council Adult Leukaemia Working Party
Sep 6, 2003·BMJ : British Medical Journal·Julian P T HigginsDouglas G Altman
Mar 3, 2004·Cancer Research·Rafael FonsecaHerve Avet-Loiseau
Mar 10, 2006·The New England Journal of Medicine·Bart BarlogieJohn Crowley
Jul 29, 2006·Blood·Michel AttalUNKNOWN Inter-Groupe Francophone du Myélome (IFM)
Apr 3, 2008·Cancer Treatment Reviews·Lisa K HicksUNKNOWN Hematology Disease Site Group of the Cancer Care Ontario Program in Evidence-based Care
Mar 11, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Andrew SpencerNola Kennedy
Jul 9, 2010·CA: a Cancer Journal for Clinicians·Ahmedin JemalElizabeth Ward
Oct 25, 2011·Blood·Gareth J MorganUNKNOWN National Cancer Research Institute Haematological Oncology Clinical Studies Group

❮ Previous
Next ❯

Citations

Oct 1, 2013·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·Isabelle Vande Broek, Peter Jacobs
Feb 7, 2013·Oman Medical Journal·Khalil Al-Farsi
Nov 22, 2015·Expert Review of Anticancer Therapy·Massimo OffidaniPietro Leoni
Sep 4, 2015·Expert Review of Hematology·María J Cejalvo, Javier de la Rubia
Mar 19, 2015·Current Medical Research and Opinion·Steven R ArikianSaad Z Usmani
Oct 19, 2013·Seminars in Oncology·Hong Liu, Philip McCarthy
Mar 29, 2014·International Journal of Laboratory Hematology·N RabinUNKNOWN United Kingdom Myeloma Forum
Aug 19, 2014·Clinical Lymphoma, Myeloma & Leukemia·Ima N Garcia
Aug 19, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Antonio PalumboMario Boccadoro
Mar 25, 2017·Blood Cancer Journal·S SengsayadethM Mohty
Feb 5, 2015·Anais Da Academia Brasileira De Ciências·Paulo Michel Pinheiro FerreiraCláudia Pessoa
Jul 4, 2018·Blood·Sara GandolfiPaul G Richardson
Sep 9, 2016·The Korean Journal of Internal Medicine·Ho Sup Lee, Chang-Ki Min
Feb 23, 2021·Oncology and Therapy·Dhauna Karam, Shaji Kumar

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.